3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
101
Glioma
43
Brain Neoplasms
28
Neuroblastoma
25
Astrocytoma
19
Gliosarcoma
15
Sarcoma, Ewing
12
Rhabdomyosarcoma
12
Neoplasms
12
Recurrence
11
Medulloblastoma
11
Sarcoma
9
Small Cell Lung Carcinoma
8
Oligodendroglioma
8
Melanoma
7
Osteosarcoma
6
Ependymoma
6
Diffuse Intrinsic Pontine Glioma
6
Central Nervous System Neoplasms
4
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Neuroendocrine Tumors
3
Neuroectodermal Tumors, Primitive
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Desmoplastic Small Round Cell Tumor
3
Colorectal Neoplasms
3
Interventions
spartalizumab
1
atezolizumab
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Everolimus
1
Erlotinib Hydrochloride
1
Disulfides
1
Contrast Media
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary leiomyomatosis and renal cell cancer
×
Temozolomide
×
1 year
×
Clear all
No trials found.